TITLE

Role of BRCA1 and BRCA2 mutations in pancreatic cancer

AUTHOR(S)
Greer, Julia B.; Whitcomb, David C.
PUB. DATE
May 2007
SOURCE
Gut;May2007, Vol. 56 Issue 5, p601
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Germline mutations in the tumour suppressor genes breast cancer antigen gene (BRCA)1 and BRCA2 have been proven to portend a drastically increased lifetime risk of breast and ovarian cancers in the individuals who carry them. A number of studies have shown that the third most common cancer associated with these mutations is pancreatic cancer. BRCA1/2 mutations are characterised by ‘allelic’ or ‘phenotypic’ heterogeneity, in that they demonstrate differing cancer expressivity between and within pedigrees that segregate their mutations. If the same mutation is present in all our cells, why do some families with a given mutation display predominantly breast cancer? Why do other lineages show a preponderance of ovarian cancer? And why would some families have members who develop mostly or exclusively pancreatic cancer-a cancer that occurs more commonly in men and that lacks consistent evidence for a hormonal basis to its aetiology-which is clearly the case for breast and ovarian cancer? The answer is that other modifying genetic and environmental factors must interact to preferentially incite carcinogenesis in one organ over another. We are just beginning to elucidate what these factors are.
ACCESSION #
25298716

 

Related Articles

  • Pancreatic carcinoma development: new etiological and pathogenetic evidence. Fiorino, Sirio; Bacchi-Reggiani, Letizia; Pontoriero, Laura; Gallo, Claudio; Chili, Elisabetta; Masetti, Michele; Zanini, Nicola; Grondona, Anna; Silvestri, Tania; Deleonardi, Gaia; Magrini, Elisabetta; Motta, Roberto; Fornelli, Adele; Bondi, Arrigo; De Biase, Dario; Baccarini, Paola; Tallini, Giovanni; Tropeano, Antonio; Cuppini, Andrea; Castellani, Gastone // Italian Journal of Medicine;2013, Vol. 7 Issue 4, p242 

    Pancreatic adenocarcinoma (PAC) is a very aggressive cancer with a poor prognosis. To date, the causes and pathogenetic mechanisms involved in the development of this malignancy remain largely unknown. Therefore, additional studies are required to improve our knowledge of the events that occur...

  • Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Tischoff, I.; Hengge, U. R.; Vieth, M.; Ell, C.; Stolte, M.; Weber, A.; Schmidt, W. E.; Tannapfel, A. // Gut;Aug2007, Vol. 56 Issue 8, p1047 

    The suppressors of cytokine signalling (SOCS) are inhibitors of cytokine signalling; methylation of SOCS-3 has been implicated in the tumorigenesis of liver as well as head and neck cancer. Aims: This study was performed to elucidate the role of SOCS-1 and SOCS-3 in Barrett's adenocarcinoma and...

  • Listing Occupational Carcinogens. Siemiatycki, Jack; Richardson, Lesley; Straif, Kurt; Latreille, Benoit; Lakhani, Ramzan; Campbell, Sally; Rousseau, Marie-claude; Boffetta, Paolo // Environmental Health Perspectives;Nov2004, Vol. 112 Issue 15, p1447 

    The occupational environment has been a most fruitful one for investigating the etiology of human cancer. Many recognized human carcinogens are occupational carcinogens. There is a large volume of epidemiologic and experimental data concerning cancer risks in different work environments. It is...

  • Etiology and Oncogenesis of Pancreatic Carcinoma. Dobrila-Dintinjana, Renata; Vanis, Nenad; Dintinjana, Marijan; Radić, Mladen // Collegium Antropologicum;Sep2012, Vol. 36 Issue 3, p1063 

    Pancreatic cancer is the fourth leading cause of cancer death overall¹. The factors that favor the development of pancreatic cancer can be divided into hereditary and acquired. Cancerogenesis is best explained by a »multi-hit« hypothesis, charcterized with the developmental sequence of...

  • Intraductal Papillary Mucinous Neoplasm of the Pancreas: An Update. Xiao, Shu-Yuan // Scientifica;2012, p1 

    Intraductal papillary mucinous neoplasm (IPMN) is a cystic tumor of the pancreas. The etiology is unknown, but increasing evidence suggests the involvement of several tumorigenesis pathways, including an association with hereditary syndromes. IPMN occurs more commonly in men, with the mean age...

  • Pancreatic carcinogenesis: The impact of chronic pancreatitis and its clinical relevance. Shrikhande, S. V.; Barreto, G.; Koliopanos, A. // Indian Journal of Cancer;Oct-Dec2009, Vol. 46 Issue 4, p288 

    Pancreatic cancer is a devastating disease with a dismal prognosis and early detection remains a challenge. On the background that inflammation is one of the key steps in the development of cancer, it is natural that chronic pancreatitis is considered as one of the etiological factors for the...

  • Genetic Predisposition to Pancreatic Cancer: A Brief Review. Greer, Julia B.; Whitcomb, David C.; Brand, Randall E. // American Journal of Gastroenterology;Nov2007, Vol. 102 Issue 11, p2564 

    The article discusses the factors concerning the pathogenesis of pancreatic cancer. It is stated that genetic aspect is often associated to the invasion of pathogens. Here, it highlights the difficulties in recognizing pancreatic-cancer prone families such as deleterious mutation, phenotypic...

  • Inside Lab Invest.  // Laboratory Investigation (00236837);Dec2000, Vol. 80 Issue 12, p1779 

    This article presents main features of December 2000 issue of the periodical "Lab Invest." Inactivation of tumor suppressor genes can be achieved by a variety of mutational mechanisms. However, it is now appreciated that restraint of such genes is often achieved through epigenetic, rather than...

  • A Case of Multiple Endocrine Neoplasia Type 2B and Gangliomatosis of Gastrointestinal Tract. Shahnazari, Banafshe; Aghamaleki, Aria; Larijani, Bagher; Reza Mohajeri Tehrani, Mohammad; Rafati, Hasan; Babamahmoodi, Abdolreza // Case Reports in Medicine;2012, p1 

    Multiple endocrine neoplasia type 2 (MEN2) is a rare familial syndrome caused by mutations in the RET protooncogene and it is transmitted as an autosomal dominant trait. The underlying problem for all the MEN syndromes is failure of a tumour suppressor gene. The genetic defect in MEN2 is on...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics